We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
-2.08%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$21.9B
AUM Growth
-$1.32B
Cap. Flow
-$7.2B
Cap. Flow %
-32.93%
Top 10 Hldgs %
17.44%
Holding
1,595
New
445
Increased
154
Reduced
119
Closed
314
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTLB icon
651
GitLab
GTLB
$5.75B
$1.85M 0.01%
36,034
+26,374
+273% +$1.54M
ZEO
652
Zeo Energy
ZEO
$18.2M
$1.77M 0.01%
+175,000
New +$1.77M
NCNO icon
653
nCino
NCNO
$2.06B
$1.73M 0.01%
+50,761
New +$1.71M
INSP icon
654
Inspire Medical Systems
INSP
$1.47B
$1.73M 0.01%
9,754
-23,272
-70% -$4.68M
MOH icon
655
Molina Healthcare
MOH
$10.4B
$1.72M 0.01%
5,222
+1,745
+50% +$562K
IS
656
DELISTED
ironSource Ltd.
IS
$1.71M 0.01%
+495,868
New +$1.89M
ALKT icon
657
Alkami Technology
ALKT
$1.96B
$1.65M 0.01%
+109,836
New +$1.6M
OSH
658
DELISTED
Oak Street Health, Inc.
OSH
$1.63M 0.01%
+66,505
New +$1.76M
BILL icon
659
BILL Holdings
BILL
$4.72B
$1.62M 0.01%
12,256
+1,498
+14% +$215K
INSM icon
660
Insmed
INSM
$22.4B
$1.61M 0.01%
+74,692
New +$1.79M
OGN icon
661
Organon & Co
OGN
$3.56B
$1.6M 0.01%
68,554
-4
-0% -$121
ENER
662
DELISTED
Accretion Acquisition Corp
ENER
$1.59M 0.01%
+160,000
New +$1.58M
IFF icon
663
International Flavors & Fragrances
IFF
$20.3B
$1.58M 0.01%
17,426
LIBYU
664
DELISTED
Liberty Resources Acquisition Corp. Unit
LIBYU
$1.53M 0.01%
150,000
PCTY icon
665
Paylocity
PCTY
$7.75B
$1.51M 0.01%
6,256
-7,441
-54% -$1.71M
RXDX
666
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$1.51M 0.01%
+25,612
New +$1.17M
SGIIU
667
DELISTED
Seaport Global Acquisition II Corp. Unit
SGIIU
$1.51M 0.01%
150,000
FEXD
668
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
$1.51M 0.01%
+150,000
New +$1.51M
ARGU
669
DELISTED
Argus Capital Corp. Class A Common Stock
ARGU
$1.51M 0.01%
+150,000
New +$1.5M
SCMA
670
DELISTED
Seaport Calibre Materials Acquisition Corp. Class A Common Stock
SCMA
$1.5M 0.01%
+150,000
New +$1.5M
LVRA
671
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$1.49M 0.01%
+150,000
New +$1.48M
HLAH
672
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$1.48M 0.01%
+150,000
New +$1.48M
CPUH
673
DELISTED
Compute Health Acquisition Corp.
CPUH
$1.48M 0.01%
+150,000
New +$1.48M
HIII
674
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$1.48M 0.01%
+150,000
New +$1.47M
BELFB
675
Bel Fuse Inc Class B
BELFB
$3.45B
$1.47M 0.01%
+58,268
New +$1.37M

Similar funds

Calamos Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Calamos Advisors held 1,595 positions worth $21.9B, down 5.7% from $23.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Calamos Advisors withdrew a net $7.2B in Q3 2022, closing 314 positions and reducing 119 holdings. Its most notable exit was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in ShoulderUp Technology Acquisition Corp. worth $20.1M.

  • Calamos Advisors's largest Q3 2022 buy was ShoulderUp Technology Acquisition Corp.: 2,000,000 shares worth $20.1M.
  • Calamos Advisors added most to Broadcom in Q3 2022, an estimated $95.8M increase.
  • Calamos Advisors's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $424M.
  • Calamos Advisors fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q3 2022, selling an estimated $122M.
  • Calamos Advisors's ten largest holdings make up 17% of its $21.9B portfolio in Q3 2022.
  • Calamos Advisors opened 445 new positions and closed 314 in Q3 2022.
  • Calamos Advisors's portfolio value fell 5.7% quarter-over-quarter to $21.9B.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.